Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy

JAMA Ophthalmol. 2024 Aug 1;142(8):740-741. doi: 10.1001/jamaophthalmol.2024.2514.
No abstract available

MeSH terms

  • Aged
  • Female
  • Glucagon-Like Peptides* / adverse effects
  • Glucagon-Like Peptides* / therapeutic use
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use
  • Male
  • Middle Aged
  • Optic Neuropathy, Ischemic* / chemically induced
  • Optic Neuropathy, Ischemic* / diagnosis
  • Optic Neuropathy, Ischemic* / drug therapy
  • Visual Acuity

Substances

  • semaglutide
  • Glucagon-Like Peptides
  • Hypoglycemic Agents